Ten Years of Change in Bariatric/Metabolic Surgery in the Asia–Pacific Region with COVID-19 Pandemic: IFSO-APC National Reports 2021 - Scorecard - MDSpire
Advertisement
Ten Years of Change in Bariatric/Metabolic Surgery in the Asia–Pacific Region with COVID-19 Pandemic: IFSO-APC National Reports 2021
Clinical Scorecard: A Decade of Evolution in Bariatric and Metabolic Surgery Across the Asia-Pacific Region Amidst the COVID-19 Pandemic: Insights from the 2021 IFSO-APC National Reports
At a Glance
Category
Detail
Condition
Obesity and type 2 diabetes mellitus (T2DM)
Key Mechanisms
Bariatric and metabolic surgery to reduce BMI and improve metabolic syndrome/T2DM
Target Population
Asian candidates with BMI ≥ 35 kg/m2 for bariatric surgery; BMI ≥ 30 kg/m2 with T2DM or metabolic syndrome for metabolic surgery
Care Setting
National bariatric/metabolic surgery centers and institutes across Asia-Pacific countries
Key Highlights
Rapid 2.5-fold increase in bariatric/metabolic surgeries in Asia-Pacific from 2013 to 2018.
Consensus indications for surgery in Asia-Pacific: BMI ≥ 35 kg/m2 for bariatric surgery; BMI ≥ 30 kg/m2 with T2DM/metabolic syndrome for metabolic surgery.
COVID-19 pandemic influenced bariatric/metabolic surgery practices across Asia-Pacific countries in 2020.
Guideline-Based Recommendations
Diagnosis
Use BMI thresholds of ≥ 35 kg/m2 for bariatric surgery candidacy.
Consider metabolic surgery for patients with BMI ≥ 30 kg/m2 who have T2DM or metabolic syndrome.
Management
Perform bariatric/metabolic surgery in specialized centers with trained bariatric surgeons.
Follow national guidelines where available for indications and procedural choices.
Monitoring & Follow-up
Track prevalence of obesity and T2DM using national and international databases (WHO, IDF).
Maintain national registries or surveys to monitor surgical volumes and outcomes.
Risks
Consider impact of COVID-19 on surgical scheduling and patient management.
Monitor for complications related to bariatric/metabolic surgery as per standard surgical protocols.
Patient & Prescribing Data
Patients with obesity and/or T2DM in Asia-Pacific countries meeting BMI criteria.
Significant increase in surgical treatment uptake over the decade; insurance coverage and national guidelines vary by country.
Clinical Best Practices
Adhere to consensus BMI thresholds for surgical indications in Asian populations.
Utilize national registries and surveys to inform practice and policy.
Adapt bariatric/metabolic surgery services in response to pandemic-related challenges.
Engage multidisciplinary teams for comprehensive preoperative and postoperative care.
by Masayuki Ohta, Soo Min Ahn, Yosuke Seki, Wah Yang, Simon Kin-Hung Wong, Suthep Udomsawaengsup, Jeffrey M. Hamdorf, Manish Khaitan, Nik Ritza Kosai, Weu Wang, June Lee, Reno Rudiman, Thejana Wijeratne, Edward Oliveros, Cunchuan Wang, Kazunori Kasama
